Human Insulin
Product Description
Wanbang Biopharmaceuticals
-
CN -
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
Categories
Specifications
Wanbang Biopharmaceuticals
-
CN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
More Products from Wanbang Biopharmaceuticals (19)
-
Product Empagliflozin Tablets
China Approved -
Product Erythropoietin for Injection (EPO)
1000iu, 2000iu, 3000iu, 4000iu, 10000iu -
Product Febuxostat
Commercial US DMF inprogress -
Product Glimepiride Tablets
China approved -
Product Guanfacine ER Tablets
USA Approved -
Product Heparin Sodium Injection
1ml:5000iu, USA approved -
Product Insulin Glargine Injection
China approved -
Product Insulin Lispro Injection
China approved -
Product Leflunomide Tablets
USA approved -
Product Liraglutide Injection
under clinical study -
Product Pitavastatin Calcium Tablets
China Approved -
Product Roxadustat Capsules
China under registration
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance